Elixinol Global has partnered with PharmaCare to release a line of CBD capsules
Elixinol Global Limited (ASX:EXL), announced today that its Dutch based subsidiary, Elixinol B.V., has partnered with the Naturopathica brand—which is owned by PharmaCare—to create a co?branded CBD capsule range.
Elixinol Global is a worldwide leader in the cannabis industry, and currently sells a wide variety of hemp?derived CBD dietary supplements, hemp food and wellness products.
The company also currently holds holding a highly valuable manufacturing licence for its medicinal cannabis subsidiary, Nunyara Pharma Pty Ltd, and is currently awaiting the approval of its cultivation license from the Australian Office of Drug Control.
Disclaimer: Past performance is not an indicator of future performance.
The product range will be sold via the network of Holland & Barrett stores, which is one of the UK's leading health and wellness retailers.
The Naturopathic "CBD+" brand includes six capsule-based Stock Keeping Units (SKU), and will combine Elixinol's high strength full spectrum CBD with vitamins and minerals that will target different areas of a user's health and wellbeing.
Elixinol has also confirmed that it is already in the process of fulfilling a second order of 60,000 CBD+ units.
"The partnership with PharmaCare positions Elixinol as a leading player in the developing UK CBD market. Naturopathica CBD+ will be sold via Holland & Barrett's online store, HollandandBarret.com, and over 800 Holland & Barrett retail stores."
– Elixinol Europe & UK CEO, Ali Atcha
Holland & Barrett is currently one of the world's leading health and wellness retailers—and the largest in Europe—which supplies a wide range of vitamins, minerals, health supplements, specialist foods and natural beauty products.
The CEO of Elixinol Global, Stratos Karousos, was bullish about the deal, saying that "Elixinol partnering with the prominent UK based PharmaCare underpins Elixinol's commitment to grow its branded products through working partnerships with the UK's most trusted and highly regarded brands."
"The Naturopathica CBD+ range is the first CBD product to appear in a prime?time television advertisement, running on the UK's Channel 4 and ITV networks."
"In June, Elixinol was the first CBD brand to leverage the UK's National Rail giant media boards, with an extensive digital marketing campaign across London's national and international train stations," Karousos said.